Not applicableUnknownNCT04015193What this trial is testingFollow-up of SPTS in Patients With Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon University Medical Center Groningen 50
Large-scale testing (Phase 3)UnknownNCT00934427What this trial is testingStudy of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon SymptomsWho this might be right forRaynaud Disease MediQuest Therapeutics 100
Not applicableStudy completedNCT03211325What this trial is testingIdentification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.Who this might be right forRaynaud's Phenomenon Isolated PrimaryRaynaud's Phenomenon (Secondary)Healthy University Hospital, Grenoble 29
Testing effectiveness (Phase 2)Ended earlyNCT04915950What this trial is testingAssess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud's Phenomenon Secondary to Systemic Sclerosis Pfizer 13
Large-scale testing (Phase 3)Not Yet RecruitingNCT07759557What this trial is testingEfficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's PhenomenonWho this might be right forSystemic Sclerosis (SSc)Raynaud Disease Secondary to Scleroderma Khon Kaen University 72
Post-approval studies (Phase 4)Ended earlyNCT03639766What this trial is testingThe Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon University of Central Florida 3
Large-scale testing (Phase 3)Looking for participantsNCT05098704What this trial is testingPreventive Effect of Clopidogrel on the Systemic Sclerosis Development RiskWho this might be right forSclerodermaSystemic Sclerosis University Hospital, Bordeaux 90
Testing effectiveness (Phase 2)Study completedNCT02228850What this trial is testingStudy of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud's Phenomenon Secondary to Systemic Sclerosis NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) 35
Not applicableWithdrawnNCT03393325What this trial is testingTadalafil-Delivra and Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Post-approval studies (Phase 4)Study completedNCT00048763What this trial is testingSafety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonWho this might be right forRaynaud's Disease Otsuka America Pharmaceutical 75
Testing effectiveness (Phase 2)Study completedNCT01926847What this trial is testingDigital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) StimulatorWho this might be right forRaynaud Disease Bayer 23
Testing effectiveness (Phase 2)UnknownNCT02356809What this trial is testingSafety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's PhenomenonWho this might be right forSecondary Raynaud's Phenomenon Artgen Biotech 30
Not applicableStudy completedNCT06291142What this trial is testingEarly Diagnosis of SSc in the General Rheumatology Clinic - PilotWho this might be right forSystemic SclerosisRaynaud Phenomenon University of Manchester 112
Early research (Phase 1)Study completedNCT00700518What this trial is testingDose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's PhenomenonWho this might be right forRaynaud's Phenomenon Procris Pharmaceuticals 10
Not applicableStudy completedNCT02683408What this trial is testingDiosmiplex (Vasculera®) in Primary and Secondary Raynaud's PhenomenonWho this might be right forRaynaud's Disease Primus Pharmaceuticals 87
Not applicableStudy completedNCT03129178What this trial is testingBeet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon University of Portsmouth 27
Large-scale testing (Phase 3)Study completedNCT04040322What this trial is testingIntravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)Who this might be right forRaynaud's Phenomenon Secondary to Systemic Sclerosis Civi Biopharma, Inc. 198
Testing effectiveness (Phase 2)Study completedNCT01090492What this trial is testingPF-00489791 For The Treatment Of Raynaud'sWho this might be right forRaynaud's DiseasePeripheral Vascular Disease Pfizer 243
Testing effectiveness (Phase 2)Study completedNCT02260557What this trial is testingEffects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud's Phenomenon Secondary to Systemic Sclerosis Actelion 74
Very early researchStudy completedNCT03027674What this trial is testingTopical 10 % Nifedipine Versus 5% Sildenafil in Secondary RaynaudWho this might be right forRaynaud Phenomenon Due to TraumaRaynaud DiseaseSystem; Sclerosis+3 more Pontificia Universidad Catolica de Chile 10